Biotėkmė, MB - company info and details

Company age: 11 y. 3 mo.

Update

Company overview

Company name Biotėkmė, MB
Company code 304066303
VAT code LT100012308518
Registered address Kauno r. sav., Karmėlava, Pušyno g. 14, LT-54447
Registration date 2015-07-02 Company age: 11 y. 3 mo.
Phone Phone
Email Email
Revenue (2025) 31,662 € +61% History
Profit (2025) 14,156 € History
Number of employees 0 History
Managed vehicles 3 List
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Small partnership
NACE activity Landscape service activities
Ownership form Private without foreign capital
Public sales amount, last 12 mos. 15,145 € List

Description

This description was generated by artificial intelligence.
Biotekme, MB (company code 304066303) is an operational private small partnership registered in 2015. It operates in the national private non-financial companies sector and is owned under Lithuanian private ownership, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. The company is governed by a CEO only and is classified as a micro enterprise. Its main activity is EVRK code O.81.30.00, Landscape service activities. The registered address is Pušyno g. 14, Karmelava, Kauno r. sav., Kauno apskr. In 2025, the company generated revenue of €31.7K and net profit of €14.2K, with a profit margin of 44.7%. This followed a weaker 2024, when revenue was €19.7K and the company recorded a net loss of €4.6K. Compared with 2024, revenue increased by 60.9% in 2025, while revenue over two years remained 18.2% lower than in 2023. At the end of 2025, equity stood at €157.7K and total assets at €162.0K, with liabilities of €4.3K and an equity ratio of 97.3%. The company had 1 average employee in 2023.

Download a detailed company report

Make confident decisions with all the information about Biotėkmė, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report